Items where authors include "Pylkäs, K."

Article

Morra, A. orcid.org/0000-0003-4983-7883, Schreurs, M.A.C. orcid.org/0000-0002-1826-5344, Andrulis, I.L. et al. (114 more authors) (2023) Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine. ISSN 2045-7634

Escala-Garcia, M., Guo, Q., Dörk, T. et al. (234 more authors) (2019) Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer, 120. pp. 647-657. ISSN 0007-0920

Guo, Q., Burgess, S., Turman, C. et al. (132 more authors) (2017) Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology, 46 (6). pp. 1814-1822. ISSN 0300-5771

Jiao, X., Aravidis, C., Marikkannu, R. et al. (103 more authors) (2017) PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. Oncotarget, 8. pp. 102769-102782. ISSN 1949-2553

Shimelis, H., Mesman, R.L.S., Von Nicolai, C. et al. (130 more authors) (2017) BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Research, 77 (11). pp. 2789-2799. ISSN 0008-5472

Ghoussaini, M, French, J.D., Michailidou, K. et al. (122 more authors) (2016) Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation. American Journal of Human Genetics, 99 (4). pp. 903-911. ISSN 0002-9297

Darabi, H., Beesley, J., Droit, A. et al. (111 more authors) (2016) Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Scientific Reports, 6. p. 32512. ISSN 2045-2322

Guo, Y., Warren Andersen, S., Shu, X.O. et al. (108 more authors) (2016) Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. PLoS Medicine, 13 (8). e1002105. ISSN 1549-1277

Wyszynski, A., Hong, C.C., Lam, K. et al. (107 more authors) (2016) An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics , 25 (17). pp. 3863-3876. ISSN 0964-6906

Hollestelle, A., van der Baan, F.H., Berchuck, A. et al. (355 more authors) (2016) No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology, 141 (2). pp. 386-401. ISSN 0090-8258

Zhao, Z., Wen, W., Michailidou, K. et al. (115 more authors) (2016) Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes and Control. pp. 1-15. ISSN 0957-5243

Dunning, A.M., Michailidou, K., Kuchenbaecker, K.B. et al. (245 more authors) (2016) Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature Genetics. ISSN 1061-4036

Easton, D.F., Lesueur, F., Decker, B. et al. (126 more authors) (2016) No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics . ISSN 0022-2593

Petridis, C., Brook, M.N., Shah, V. et al. (92 more authors) (2016) Genetic predisposition to ductal carcinoma in situ of the breast. Breast Cancer Research, 18 (1). 22. ISSN 1465-542X

Hamdi, Y., Soucy, P., Adoue, V. et al. (93 more authors) (2016) Association of Breast Cancer Risk with Genetic Variants Showing Differential Allelic Expression: Identification of a Novel Breast Cancer Susceptibility Locus at 4q21. Oncotarget, 7. pp. 80140-80163. ISSN 1949-2553

Jamshidi, M., Fagerholm, R., Khan, S. et al. (55 more authors) (2015) SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival. Oncotarget, 6 (35). pp. 37979-37994. ISSN 1949-2553

Wishart, G.C., Bajdik, C.D., Dicks, E. et al. (34 more authors) (2012) PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. British Journal of Cancer, 107. pp. 800-807. ISSN 0007-0920